Laín S - Search Results

1

Lipids Shape the Electron Acceptor-Binding Site of the Peripheral Membrane Protein Dihydroorotate Dehydrogenase.

Costeira-Paulo J, Gault J, Popova G, Ladds MJGW, van Leeuwen IMM, Sarr M, Olsson A, Lane DP, Laín S, Marklund EG, Landreh M. Costeira-Paulo J, et al. Among authors: lain s. Cell Chem Biol. 2018 Mar 15;25(3):309-317.e4. doi: 10.1016/j.chembiol.2017.12.012. Epub 2018 Jan 18. Cell Chem Biol. 2018. PMID: 29358052 Free PMC article.

2

Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.

Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP. Fåhraeus R, et al. Among authors: lain s. Curr Biol. 1996 Jan 1;6(1):84-91. doi: 10.1016/s0960-9822(02)00425-6. Curr Biol. 1996. PMID: 8805225 Free article.

3

Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1.

Ball KL, Lain S, Fâhraeus R, Smythe C, Lane DP. Ball KL, et al. Among authors: lain s. Curr Biol. 1997 Jan 1;7(1):71-80. doi: 10.1016/s0960-9822(06)00029-7. Curr Biol. 1997. PMID: 8999999 Free article.

4

Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.

Fåhraeus R, Laín S, Ball KL, Lane DP. Fåhraeus R, et al. Among authors: lain s. Oncogene. 1998 Feb 5;16(5):587-96. doi: 10.1038/sj.onc.1201580. Oncogene. 1998. PMID: 9482104

5

Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function.

Laín S, Xirodimas D, Lane DP. Laín S, et al. Exp Cell Res. 1999 Dec 15;253(2):315-24. doi: 10.1006/excr.1999.4672. Exp Cell Res. 1999. PMID: 10585254 Review. No abstract available.

6

Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Rodriguez MS, et al. Among authors: lain s. Mol Cell Biol. 2000 Nov;20(22):8458-67. doi: 10.1128/MCB.20.22.8458-8467.2000. Mol Cell Biol. 2000. PMID: 11046142 Free PMC article.

7

Therapeutic exploitation of the p53 pathway.

Lane DP, Lain S. Lane DP, et al. Among authors: lain s. Trends Mol Med. 2002;8(4 Suppl):S38-42. doi: 10.1016/s1471-4914(02)02309-2. Trends Mol Med. 2002. PMID: 11927286 Review.

8

Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.

Camus S, Higgins M, Lane DP, Lain S. Camus S, et al. Among authors: lain s. FEBS Lett. 2003 Feb 11;536(1-3):220-4. doi: 10.1016/s0014-5793(03)00054-1. FEBS Lett. 2003. PMID: 12586367 Free article.

9

Improving cancer therapy by non-genotoxic activation of p53.

Lain S, Lane D. Lain S, et al. Eur J Cancer. 2003 May;39(8):1053-60. doi: 10.1016/s0959-8049(03)00063-7. Eur J Cancer. 2003. PMID: 12736103 Review.

10

P53 abnormalities and outcomes in colorectal cancer: a systematic review.

Munro AJ, Lain S, Lane DP. Munro AJ, et al. Among authors: lain s. Br J Cancer. 2005 Feb 14;92(3):434-44. doi: 10.1038/sj.bjc.6602358. Br J Cancer. 2005. PMID: 15668707 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters